Korea Investment Partners

Korea Investment Partners (KIP) is a prominent venture capital and private equity firm based in Seoul, South Korea, with over 30 years of experience in the industry. Established in 1986, KIP focuses on investing in innovative companies across various sectors, including biotechnology, healthcare, media, financial technology, and information technology. The firm has a diverse portfolio that includes notable companies such as Kakao, Naver, and YG Entertainment. KIP manages more than 20 venture and private equity funds, with total assets under management amounting to approximately $1.8 billion. In addition to its headquarters in Seoul, KIP operates offices in Shanghai, Beijing, and Sunnyvale, showcasing its commitment to global investment opportunities.

Yer-hyun Baek

CEO and President

Steve Hong

Manager

Sang Hyuk Jang

Associate

Hyeong-sun Jeon

Principal

Dong-yeob Kim

Executive Director

Min-kyu Kim

Director

Yong-Jae Kim

Head of Management Support, MD

Kun-ho Kim

Principal

Won-Bae Lee

Executive Director

Ke Liu

Principal

Minsik Park

Director

Jin-han Park

Senior Principal

Hyeong-jun Park

Principal

Young-ho Park

Senior Principal

Deok-joon Shin

Director

Sung-wook Yoo

Principal

228 past transactions

Jenfi

Funding Round in 2023
Jenfi Pte Ltd is a financial technology company based in Singapore that specializes in providing revenue-based financing to small and medium-sized enterprises in Asia. Founded in 2019, Jenfi focuses on assisting digitally-enabled businesses, including e-commerce ventures and high-growth startups, by offering funds to enhance their sales velocity. The company enables these businesses to finance their marketing efforts, inventory needs, and growth initiatives, thereby supporting their development and expansion in a competitive market.

Bluesignum

Seed Round in 2023
We are developing a digital mental health guide that combines cognitive behavioral therapy techniques and Artificial Intelligence to help people self-manage their mental health. BlueSignum aims to go beyond the habit app space and build out its more complex services, establishing itself in the global healthcare app market. The AI Listener service BlueSignum is currently building will allow users to have a conversation with an AI speaker.

NRISE

Series B in 2022
NRISE is develops MOCI and WIPPY services. NRISE research and develops social media services to bring people the joy of communication.

XYZ

Series A in 2022
LoungeLAB is a Retail-tech startup that augments space with technology, using the state-of-the-art technologies such as AI and Robotics technology. LoungeLAB focuses on enhancing the product value and services, and we develop in the field rather than on the desk. We Invent Everyday Technology for All.

Apposter

Series B in 2022
Apposter is a Korean-based interactive solutions company engaged in providing UI development, app development, and mobile business consultancy solutions to its customers. Apposter has released many mobile apps and solutions to the enterprise market including, Fotofly, Life Valley, and Tok Song.

Innogen Pharmaceutical

Venture Round in 2022
Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing, and R&D company.

Interior Teacher

Series A in 2022
Interior Teacher is solidifying its position as a premium home styling service.

Genieworks

Series B in 2022
Genieworks is pioneering new business with creative ideas and technology.

Toffee Pie

Series B in 2022
Toffee Pie is a retailer of bras in different sizes. They develop bras of different sizes and shapes, enabling customers with different needs to access suitable underwear. They offer a large-cup underwear brand that researches and develops bras for big-breasted girls.

Jaranda

Series B in 2022
Jaranda Co., Ltd. owns and operates a platform that integrates teachers, parents, and students. The company is based in Seoul, South Korea.

Catch Table

Series C in 2022
Operator of a restaurant management platform intended to provide restaurant reservation services. The company's platform helps to book tables in restaurants to manage reservations, enabling customers to search by desired conditions such as date, time, and number of people and make real-time reservations.

Doosan Mobility Innovation

Venture Round in 2022
Doosan Mobility Innovation focuses on the mobile applications of fuel cell technology.

Mighty Jaxx

Series A in 2022
Mighty Jaxx International Pte Ltd designs and manufactures toy collectibles and lifestyle products. It offers three-dimensional art figures. The company also develops a blockchain-based online platform for issuing and validating tamper-resistant and permanent certificates to designer toys and collectibles. It also offers monetary rewards through Mighty Assembly VIP Programme. The company offers its products through retailers, stores, and an online portal. The company was founded in 2012 and is based in Singapore.

Geneos Therapeutics

Series A in 2022
Geneos Therapeutics, Inc. specializes in the production and development of neoantigen-targeting cancer immunotherapies. Founded in 2016 and based in Plymouth Meeting, Pennsylvania, the company utilizes its Geneos Platform to create personalized therapies that are specifically tailored to the unique tumor mutations of each patient. By identifying relevant neoantigen targets from individual tumors, Geneos aims to develop innovative treatments that provide targeted immunotherapies for cancer patients, enhancing the potential for effective disease management and cure.

Fast Forward

Series A in 2022
Fast Forward is an app development company that operates DOMINO, an investment management app.

Torder

Seed Round in 2022
Torder is a technology company that has transitioned from its original focus on a tablet ordering and advertising platform to a broader aim of facilitating unattended control of devices from any location. By utilizing a glass panel rather than traditional plastic touch panels, Torder enhances the user experience while optimizing operational efficiency. The company’s innovative approach allows clients to lower their monthly expenses while providing a comfortable interface for consumers. This evolution positions Torder as a next-generation leader in the tech space, dedicated to streamlining device management and enhancing user accessibility.

Loco

Series A in 2022
Loco, a live trivia game show app. Loco offers an interactive trivia game show that lets users answer 10 multiple choice questions and win money in real time. The game’s prize money is Rs 10,000 and winners can get their reward directly into their Paytm account. The live quiz covers topics such as current events, technology, food, sports, religion, politics, music, movies and history, according to information available on its Google Play store page.

Mighty Jaxx

Series A in 2022
Mighty Jaxx International Pte Ltd designs and manufactures toy collectibles and lifestyle products. It offers three-dimensional art figures. The company also develops a blockchain-based online platform for issuing and validating tamper-resistant and permanent certificates to designer toys and collectibles. It also offers monetary rewards through Mighty Assembly VIP Programme. The company offers its products through retailers, stores, and an online portal. The company was founded in 2012 and is based in Singapore.

Rizzle

Series B in 2022
Rizzle is a 60-second video platform that specializes in talk shows and drama, positioning itself as a leading provider of original short-form content. The platform uniquely integrates creation, distribution, and monetization, allowing users to produce and share videos while also enabling sponsorship opportunities. Rizzle's application leverages artificial intelligence to facilitate the video-making process and fosters a global community of content creators. Users can connect with friends, family, and social media, engaging in creative expression through short series, videos, and reels, all at no cost. This approach not only enhances the user experience but also cultivates a vibrant hub for creative collaboration.

PILAB

Series A in 2022
PILAB is a research-focused blockchain company that develops multipurpose software that enables communication and management of data across different platforms. PILAB is backed by South Korean venture capital firm Korea Investment Partners.

MORAI

Series B in 2022
MORAI Inc. is a company that specializes in developing a simulation platform designed to create three-dimensional virtual environments that closely mimic real road conditions. This platform is utilized to test and enhance autonomous driving algorithms, providing essential verification and validation solutions for autonomous vehicles. Additionally, MORAI offers datasets that support the development of advanced driving algorithms. Established in 2018 and headquartered in Seoul, South Korea, the company also operates an office in San Francisco, California.

Newlinks Technology

Series E in 2022
Newlinks Technology is a car refueling service provider, mainly providing one-button cardless refueling service. The application recommends a gas station for the user and offers membership subscription, discounts, and more. In addition, it also provides car maintenance, 4S services, tire services, auto insurance, car care, and other services. Newlinks Technology was founded on 2016.

Loadcomplete

Series B in 2022
Loadcomplete (로드컴플릿) is a social and mobile game developer in Korea. It develops games such as Tap Tap Heroes, Disco Panda, Bumping Bears, Play Kale, Trino, and Blue Heart for iOS and Android devices. Loadcomplete was founded in December 2009.
Pavilion Data Systems Inc. specializes in the design and development of NVMe-over-Fabric storage platforms that cater to massively-parallel applications. The company offers innovative solutions, including OPENCHOICE, which revolutionizes traditional storage procurement and deployment methods, and Pavilion Data OS, enabling Internet and SaaS companies, cloud service providers, and enterprises to efficiently manage critical applications. Pavilion's products deliver exceptional storage performance and density while avoiding the complexities associated with legacy all-flash arrays. By utilizing Hyperparallel Flash Arrays, which incorporate multiple controllers to maximize the advantages of flash technology, Pavilion achieves ultra-low latency and linear scalability, addressing the growing demand for enhanced data throughput across various sectors, including financial services, government, media, and research. Founded in 2011 and headquartered in San Jose, California, Pavilion Data Systems also maintains offices in Schiphol, the Netherlands, and Pune, India.

AIONCO KOREA Co

Series B in 2021
AIONCO KOREA provides competitive item sourcing and logistics solution service to cross border eCommerce clients. AIONCO specializes in the delivery of exceptional Multi-Channel Fulfillment solutions. From pallets to beautifully gift wrapped packages, they provide a streamlined, single-source solution that optimizes the supply chain across all channels for brands in both the direct-to-consumer and wholesale arenas. The company was established in 2015 and is based in Seoul, Korea.

Spatial

Series B in 2021
Spatial Systems, Inc. is a New York-based company founded in 2016 that offers an augmented workplace platform designed to enhance collaboration and productivity. The platform enables users to conduct meetings using spatial audio and 3D telepresence, facilitating a more immersive interaction. It also allows for the sharing and organization of various digital content, such as 3D models, videos, documents, images, and websites, effectively transforming traditional work environments into dynamic digital workspaces. By leveraging cutting-edge technology, Spatial aims to empower individuals and organizations to unlock their creative potential and improve connectivity. The company has attracted investment from notable venture firms and angel investors, underscoring its innovative approach within the augmented reality and virtual reality sectors.

Viron Inc.

Series B in 2021
OncoMyx Therapeutics, Inc. is a biotechnology company specializing in the development of oncolytic immunotherapies utilizing the myxoma virus (MYXV) to stimulate immune responses against cancer. Founded in 2018 and based in Phoenix, Arizona, the company focuses on targeting both hematologic and solid tumors through its innovative MYXV platform. This platform employs a novel systemic delivery method that allows the myxoma virus to be carried by human leukocytes, enabling it to effectively infect tumor cells. By assembling a highly skilled team in oncolytic virus research, OncoMyx aims to advance a pipeline of therapeutic options designed to improve outcomes for cancer patients.

Viron Inc.

Series B in 2021
OncoMyx Therapeutics, Inc. is a biotechnology company specializing in the development of oncolytic immunotherapies utilizing the myxoma virus (MYXV) to stimulate immune responses against cancer. Founded in 2018 and based in Phoenix, Arizona, the company focuses on targeting both hematologic and solid tumors through its innovative MYXV platform. This platform employs a novel systemic delivery method that allows the myxoma virus to be carried by human leukocytes, enabling it to effectively infect tumor cells. By assembling a highly skilled team in oncolytic virus research, OncoMyx aims to advance a pipeline of therapeutic options designed to improve outcomes for cancer patients.

Limbix

Series A in 2021
Virtual is a developer of prescription digital therapeutics platform intended to help mental health treatment. The company's tool adheres to strict compliance with FDA quality management standards and also is put through rigorous research trials and in certain cases is paired with existing pharmacological treatments, as well as uses virtual reality to administer VR exposure therapy, assign CBT assessments or exercises and track patient progress, enabling patients to overcome anxiety, phobia and obsessive-compulsive disorder easily.

PDC*line Pharma

Series B in 2021
PDC*line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens. PDC*line Pharma originated from a flagship R&D program of the French Blood Bank (EFS, Etablissement Français du Sang) where PDC*line, a proprietary Plasmacytoid Dendritic Cell line (PDC) was developed from a patient with a PDC leukemia. Laurent LEVY President France & COO, and Joel PLUMAS, CSO founded the company in April 2014 in Grenoble and took the project to the clinical development stage with non-dilutive funding. Eric Halioua joined the team in February 2016, and became President and CEO in July 2016.

Kangdesai Medical Technology

Seed Round in 2021
Kandesai is a personalized tumor immunotherapy developer, focusing on the development of immunotherapy platforms based on tumor neoantigens. It has independently developed 3 tumor drug pipelines based on neoantigens and innovative pipelines for liver cirrhosis with independent intellectual property rights. Help patients suppress tumor recurrence and metastasis.

Contents Lab. Blue

Series A in 2021
Contents Lab. Blue is a webtoon production company that makes 'novel comics' based on Internet novels, upcycles comic books into webtoons, develops Internet novels as a source for other media adaptations, and translates and localizes popular webtoons for many different countries.

ONDA

Series B in 2021
T Port Inc. is an accommodation management platform. T Port Inc.'s real-time reservation management book can easily manage all bookings on the computer or smartphone anytime, anywhere.

1939

Venture Round in 2021
1939 Games ehf. is an indie game development studio based in Reykjavík, Iceland, founded in 2015 by former veterans of CCP. The company specializes in creating World War II-themed gaming experiences, with a primary focus on developing a digital collectible card game titled KARDS. This game integrates familiar elements from the card game genre while incorporating classic World War II themes, aiming to deliver an engaging and action-packed experience for players. By blending historical facts with gameplay, 1939 Games seeks to provide a unique role-playing experience that appeals to both card game enthusiasts and history buffs alike.

Aulton

Series B in 2021
Aulton New Energy Automotive Technology Co., Ltd. specializes in developing battery swapping technology for electric vehicles in China. Headquartered in Shanghai, with an additional office in Guangzhou, the company manufactures equipment for quick battery exchanges and manages power stations that facilitate the installation of batteries in taxis and vehicles used for car-hailing services. Aulton also offers energy management services and has created an automated chassis replacement system that allows for the disassembly and installation of batteries in a fully automated environment, significantly reducing the time required for battery replacement to just a few minutes.

GenEdit

Series A in 2021
GenEdit, Inc. focuses on the development of novel, non-viral, nanoparticle-based delivery technology and enabling next generation CRISPR-based gene therapies. The foundation of our CRISPR-Nanoparticle Technology Platform is based on successfully engineering the individual components of the CRISPR system to overcome the limitations of existing delivery vehicles for CRISPR-based therapeutics.

Sellerhub

Series B in 2021
Seller Hub Co., Ltd provides solutions for shopping malls. The company provides solutions such as self contract event, hub X Koolmin card, courier contract, amd hub X coupang. Seller Hub Co., Ltd was incorporated in 2012 and is based in Seoul, South Korea.

Gametales

Seed Round in 2021
Developer of mobile games platform designed to organize gaming leagues for amateur as well as professional players. The company's gaming platform offers a virtual reality experience and a variety of games and gaming tournaments online, enabling game enthusiasts to showcase their skills and win prizes.

Mighty Jaxx

Series A in 2021
Mighty Jaxx International Pte Ltd designs and manufactures toy collectibles and lifestyle products. It offers three-dimensional art figures. The company also develops a blockchain-based online platform for issuing and validating tamper-resistant and permanent certificates to designer toys and collectibles. It also offers monetary rewards through Mighty Assembly VIP Programme. The company offers its products through retailers, stores, and an online portal. The company was founded in 2012 and is based in Singapore.

Eyevensys

Series B in 2021
Eyevensys S.A.S. develops non-viral gene therapy treatments for ophthalmology. The company’s develops Electro-Transfection (ET) of plasmids to the ciliary muscle therapy to deliver calibrated and sustained therapeutic proteins preferentially in the vitreous for several months. It develops an Electro-Transfection Injection System (ETIS) which is a drug device solution consisting of a device and a pulse generator. The company focuses on Uveitis, age-related macular degeneration (AMD), and retinopathies, including Central Retinal Vein Occlusion (RVO) and Diabetic Retinopathy (DR/DME). Eyevensys S.A.S. was incorporated in 2008 and is based in Paris, France.

S-Alpha Therapeutics

Series A in 2021
S-Alpha Therapeutics Inc., a digital therapeutics company, researches and develops health applications and platform technologies that enable digital devices to treat different diseases. Its products include SAT-001, an ophthalmology related application for eye disease treatment; SAT-002, neurology application for treatment of nervous system disease; SAT-003, oncology application for recovery and treatment of cancer patients; and SAT-008, a public crisis application for overcoming social problems. Additionally, it also develops therapeutic devices. The company was founded in 2019 and is based in Seoul, South Korea.

SK Plasma

Series E in 2021
SK Plasma Co., Ltd., established in 2015 and based in Seongnam-si, South Korea, specializes in the production of plasma-derived products. The company focuses on essential medicines that address various health conditions, including hypoalbuminemia, hemorrhagic shock, antithrombin deficiency, and tetanus, as well as providing prevention and treatment solutions for hepatitis B. As a subsidiary of SK Chemicals Co., Ltd., SK Plasma has gained recognition for its high-quality products and services, particularly in the export market. The company's plasma fractionation business plays a crucial role in promoting human health, enabling healthcare providers to deliver effective treatments for congenital immunodeficiency diseases and hemophilia, thereby contributing to the overall well-being of society.

MAXVAX

Series A in 2021
MAXVAX focuses on the development and commercialization of innovative vaccines targeting viral diseases, including rotavirus, shingles, and herpes. By leveraging advanced vaccine technology, the company aims to enhance treatment options within the biotechnology sector. MAXVAX's goal is to provide healthcare professionals with effective tools to improve patient care and outcomes in the fight against these viral infections.

Fast Forward

Seed Round in 2021
Fast Forward is an app development company that operates DOMINO, an investment management app.

Fast Five

Series E in 2021
Fast Five is a premium SOHO office business center that aims to become an offline social network based on Fast Five membership. FAST FIVE is a membership-based premium SOHO office that offers a great business space at a reasonable price without deposit. At FAST FIVE, they aim to become an offline social network that creates a strong bond through a community manager who resides to create friends and partners with famous people from various fields such as founders, investors, professionals, and freelancers.

Inflearn

Series A in 2021
Operator of an online education platform intended for sharing and teaching IT knowledge. The company's platform has lectures conducted by expert IT personnel on various topics like python and data analytics, enabling students to reach out to IT experts who are willing to share their domain expertise.

Innogen Pharmaceutical

Venture Round in 2021
Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing, and R&D company.

Tribe

Venture Round in 2021
Tribe Accelerator, based in Singapore, is the first government-supported blockchain accelerator in the country. It aims to foster collaboration and growth within the blockchain ecosystem by providing a platform for promising startups to develop innovative solutions. Tribe Accelerator focuses on product development and offers support in business development, marketing strategies, and fundraising. It is backed by prominent organizations, including multinational corporations and top blockchain companies, which enhances its ability to connect startups with valuable resources and expertise. As a part of Tribe Group, it serves as a neutral facilitator for startups to engage with global corporations and government agencies, driving the advancement of blockchain technology.

Algorithm LABS

Series A in 2021
Developer of artificial intelligence platform designed to educate industry experts on how to plan and research and develop projects. The company's platform provides industry-specific artificial intelligence training through lectures and practical content with AI cognitive interaction system applied, enabling businesses to solve problems in planning to commercialization and improve their productivity.

Geneos Therapeutics

Series A in 2021
Geneos Therapeutics, Inc. specializes in the production and development of neoantigen-targeting cancer immunotherapies. Founded in 2016 and based in Plymouth Meeting, Pennsylvania, the company utilizes its Geneos Platform to create personalized therapies that are specifically tailored to the unique tumor mutations of each patient. By identifying relevant neoantigen targets from individual tumors, Geneos aims to develop innovative treatments that provide targeted immunotherapies for cancer patients, enhancing the potential for effective disease management and cure.

Trenbe

Series B in 2021
Trenbe Inc. sells apparel, bags, shoes, and accessories online for men and women. The company was incorporated in 2016 and is based in Seoul, South Korea.

NRISE

Seed Round in 2020
NRISE is develops MOCI and WIPPY services. NRISE research and develops social media services to bring people the joy of communication.

MicuRx Pharmaceuticals

Series E in 2020
MicuRx discovers and develops novel antibiotics to combat drug resistant bacterial infections. Founded in 2007, MicuRx employs a hybrid U.S./China business model to capitalize on the global opportunities afforded by U.S. research and development coupled with the high-quality, cost-efficient infrastructure and scientific resources available in China. This hybrid business model enables MicuRx to implement an accelerated global development strategy with a goal of completing Phase II trials for its drug candidates in both the United States and China.

Univercells

Series C in 2020
Univercells SA, founded in 2013 and based in Gosselies, Belgium, specializes in the design, development, and implementation of single-use bioprocess solutions for biomanufacturing. The company offers a comprehensive range of services, including the design and construction of manufacturing facilities, as well as the maintenance and supply of bulk active pharmaceutical ingredients (APIs). With a focus on vaccines and biologics, Univercells employs innovative engineering techniques that significantly reduce investment needs by over 75% and lower production costs by up to 90%. Their approach integrates three manufacturing steps—cell culture under perfusion, clarification, and capture—into a simulated continuous mode, enhancing efficiency in the production of antibodies, proteins, and vaccines. Additionally, Univercells has established a strategic partnership with Takeda Pharmaceutical Company to further advance its capabilities in the biomanufacturing sector.

Yibai Technology

Series A in 2020
Yibai Technology is a specialist in healthcare-based software-as-a-service.

EJN

Series A in 2020
EJN Corp. owns and operates online community platforms and services for gamers. The company offers e-sports platform Battle.dog, which analyzes the viewing data of e-sports competitions; and Twip an online sales channel for creators and streamers; and Twitch, an online social community for games. It also offers community and payment services for game video streaming services. EJN Corp. was incorporated in 2016 and is based in Seoul, South Korea.

Prokarium

Series B in 2020
Prokarium is a biopharmaceutical company based in London, United Kingdom, specializing in the development of innovative vaccination and cancer immunotherapy solutions through synthetic biology. Founded in 2007, Prokarium focuses on creating targeted vaccines that generate broad immune responses, including mucosal, systemic, and cellular immunity. Their product portfolio includes Vaxonella, which is designed to effectively stimulate immune responses by traversing the gastrointestinal tract, as well as vaccines for various infectious diseases such as Clostridium difficile, Chlamydia trachomatis, plague, and typhoid fever. Prokarium's research aims to enhance the safety and immunogenicity of its bivalent vaccine candidates, contributing to advancements in both infectious disease prevention and cancer treatment.

EVOS eSports

Series B in 2020
EVOS eSports, established in 2016 and based in Jakarta, Indonesia, is a prominent eSports organization that manages competitive teams across various games, including Dota 2, League of Legends, and Arena of Valor. The company is focused on developing an online sports platform aimed at enhancing the eSports landscape in Southeast Asia. This platform is designed to support professional players and content creators by providing essential infrastructure, enabling them to establish a reputation for professionalism in competitive gaming. EVOS eSports offers comprehensive support for its teams, which includes in-game coaching, training facilities, and mental wellness care. In addition to its team management, the organization also retails merchandise such as t-shirts, bands, caps, and lanyards through its online store.

Virogin Biotech

Series C in 2020
Virogin Biotech Ltd. ("Virogin") was founded in 2015, with the headquarters located in Vancouver, Canada. They are dedicated to developing the next generation of oncolytic virus (OV) therapeutics using their novel Synerlytic™ technical platform for improved cancer treatment. By exploring innovative approaches to immunotherapy, Virogin is committed to becoming a world leader in the field of immuno-oncology.

Virogin Biotech

Series C in 2020
Virogin Biotech Ltd. ("Virogin") was founded in 2015, with the headquarters located in Vancouver, Canada. They are dedicated to developing the next generation of oncolytic virus (OV) therapeutics using their novel Synerlytic™ technical platform for improved cancer treatment. By exploring innovative approaches to immunotherapy, Virogin is committed to becoming a world leader in the field of immuno-oncology.

Cashkaro

Series B in 2020
Cashkaro is India's Largest Cashback & Coupons site. They are backed by Mr. Ratan Tata & one of India's leading VC firms, Kalaari Capital. With over 2 million registered users, CashKaro is a one stop destination for savings across 1500+ ecommerce sites like Amazon.in, Flipkart, Paytm etc. With CashKaro.com you can now EARN CASHBACK every time you shop online with retailers like Paytm, Jabong, Shopclues, Nykaa & 1500 more! Just visit CashKaro.com and then go to the website/s of your choice from here. All you need to do is shop normally & Cashback will be auto applied on checkout. When you visit retailers via CashKaro.com and shop online, retailers pay them commission and from this commission they pay you Cashback. They work with over 1500+ top websites in India and you can earn Cashback on almost all of them. They have partnered with Amazon.in, Flipkart, Nearbuy, ShopClues, Zivame, Dominos, MakeMyTrip & so many more.

Gaussian Robot

Series B in 2020
Gaussian Robot, founded in 2013 and headquartered in Shanghai, China, specializes in the development and manufacture of commercial automatic sweeping robots. The company offers a range of products, including commercial cleaning robots, unmanned sanitation vehicles, security robot solutions, and building distribution robots. Gaussian Robot utilizes advanced technologies, such as simultaneous localization and mapping (SLAM), to enhance the capabilities of its autonomous robots. These innovations cater to various commercial applications, providing effective solutions for cleaning, surveillance, and facility management within the robotics industry.

Newlink

Series D in 2020
Newlink primarily operates as a digital energy service provider. It promotes energy change, the energy Internet of Things EIoT, and an energy new retail platform. It is a dual-material unicorn at home and abroad, one of the world's top 500 new energy companies, with more than 3,000 employees. Covering oil, electricity, hydrogen, and gas multiple energy categories, opening up the upstream and downstream of the energy industry chain, and digitally reconstructing the energy ecology.

Newlinks Technology

Series D in 2020
Newlinks Technology is a car refueling service provider, mainly providing one-button cardless refueling service. The application recommends a gas station for the user and offers membership subscription, discounts, and more. In addition, it also provides car maintenance, 4S services, tire services, auto insurance, car care, and other services. Newlinks Technology was founded on 2016.

eBrace

Series B in 2020
Guangzhou eBrace Biotechnology Co., Ltd. specializes in the research, development, production, and sale of orthodontic biological materials and digital 3D printing technologies. Founded in 2010 and headquartered in Guangzhou, China, the company offers a range of products including 3D custom printed orthodontic teeth, dentures, and personalized lingual and bracketless invisible appliances. eBrace is committed to providing detailed and accurate dental solutions, leveraging advanced 3D printing equipment to meet the needs of its customers in the orthodontics sector.

Oasis Market

Venture Round in 2020
Oasis Co., Ltd. operates as an online grocery delivery platform. It offers convenience food, agricultural products, livestock, aquatic products, health/beverage, seasoning, general food, and side dishes. The company also operates offline stores and provides early morning delivery. The company was founded in 2011 and is based in Seoul, South Korea. Oasis Co., Ltd. operates as a subsidiary of GaeaSoft Corp.

JF Chuxing

Seed Round in 2020
JF Chuxing is a chinese personalized car rental service platform.

Laundrygo

Series B in 2020
Laundrygo is a on-demand laundry service.

Haoxinqing

Series A in 2020
Haoxinqing is an online medical service platform focusing on the fields of mental psychology and chronic disease management.

Medizen Humancare

Series B in 2020
MEDIZEN HUMANCARE Inc., a research company, engages in the genomic analysis to predict diseases on an individual basis in Asia, the Americas, Europe, and internationally. Its services include M-CHECK, which provides an analysis of patients’ risk for genetic diseases using genomic variation packages related to specific diseases with gene chips or analysis kits; and MELTHY (DTC), a DNA analysis service. The company was founded in 2012 and is based in Seoul, South Korea.

Rabbit Care

Series B in 2020
Rabbit Care is your first choice for insurance and banking advise. We provide great customer experience through our digital platform and customer care center.

Actym Therapeutics, Inc.

Series A in 2020
Actym is a biotechnology company that focuses on developing an immuno-oncology platform. It specializes in the fields of medical device, manufacturing, and distribution. It focuses on a novel tumor-targeting, systemically-delivered STING pathway agonist that demonstrates robust anti-tumor. It was founded in 2017 and headquartered in San Francisco, California.

Jenfi

Seed Round in 2020
Jenfi Pte Ltd is a financial technology company based in Singapore that specializes in providing revenue-based financing to small and medium-sized enterprises in Asia. Founded in 2019, Jenfi focuses on assisting digitally-enabled businesses, including e-commerce ventures and high-growth startups, by offering funds to enhance their sales velocity. The company enables these businesses to finance their marketing efforts, inventory needs, and growth initiatives, thereby supporting their development and expansion in a competitive market.

Swiggy

Series I in 2020
Swiggy designs an on-demand food delivery platform that brings food from neighborhood restaurants directly to users' doors. The company's food delivery platform lists local restaurants and menu lists on an app for users to order from and track delivery of its delivery executives, enabling users to order food with speed and convenience. Its service is used to pick up and drop off a diverse array of items, including laundry and document or parcel deliveries to business clients and retail customers. Swiggy was founded by Sriharsha Majety, Nandan Reddy, and Rahul Jaiminiin in 2014 and is headquartered in Bangalore, Karnataka, India.

Zhenge Biotech

Series A in 2020
Shanghai ZhenGe Biotechnology Co.,Ltd. researches and develops drugs. It also engages in mammalian cell line development, upstream development, downstream development, and formulation development for various protein therapeutics. In addition, the company provides contract development and manufacturing services; and offers IND and BLA filing services. Further, it provides platform for research and development of antibodies, transient infection, process development, N-Glycosylation, and CAR-T. Shanghai ZhenGe Biotechnology Co.,Ltd. was founded in 2017 and is based in Shanghai, China.

Seculetter

Series B in 2020
SecuLetter Co.,Ltd. develops, manufactures, and markets cyber security appliances to detect unknown attacks with hybrid approaches. Its products include SecuLetter Email (SLE), a threat analysis protection solution for email that blocks cyber attacks which use malicious code; and SecuLetter FileServer (SLF), a threat analysis protection solution for fileserver that blocks the attack via attachment which targets organization that shares files server for co-work. The company was founded in 2015 and is based in Seongnam-si, South Korea.